BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26278989)

  • 1. [Surveillance after prostate cancer radiotherapy: Evaluation and management of toxicity and relapse].
    Dupic G; Hennequin C
    Cancer Radiother; 2015 Oct; 19(6-7):582-9. PubMed ID: 26278989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment for biochemical relapse after radiotherapy.
    Quero L; Hennequin C
    Cancer Radiother; 2014 Oct; 18(5-6):540-4. PubMed ID: 25179255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance after prostate cancer radiotherapy].
    Supiot S; Rio E; Clément-Colmou K; Bouchot O; Rigaud J
    Cancer Radiother; 2011 Oct; 15(6-7):540-5. PubMed ID: 21795093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Conservative management of early bladder rupture after postoperative radiotherapy for prostate cancer.
    Aherne NJ
    Urol J; 2009; 6(2):145. PubMed ID: 19472138
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy.
    Moman MR; van der Poel HG; Battermann JJ; Moerland MA; van Vulpen M
    Brachytherapy; 2010; 9(2):119-25. PubMed ID: 19850536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer.
    Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G
    Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Salvage treatments following prostate radiation therapy: role of the urologist].
    Soulié M; Salomon L;
    Cancer Radiother; 2014 Oct; 18(5-6):535-9. PubMed ID: 25175343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
    Chang JH; Park W; Park JS; Pyo H; Huh SJ; Choi HY; Lee HM; Jeon SS; Seo SI
    Int J Urol; 2015 Jan; 22(1):82-7. PubMed ID: 25208624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life after radiotherapy for prostate cancer].
    Joly F; Degrendel AC; Guizard AV
    Cancer Radiother; 2010 Oct; 14(6-7):519-25. PubMed ID: 20728393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.
    Barkati M; Williams SG; Foroudi F; Tai KH; Chander S; van Dyk S; See A; Duchesne GM
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1889-96. PubMed ID: 21550182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
    Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
    Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
    BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity].
    Hétet JF; Colls P; Pocholle P; Chauveau P; Barré C; Hallouin P
    Cancer Radiother; 2014 Nov; 18(7):701-8. PubMed ID: 24910288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salvage brachytherapy for prostate cancer biochemical recurrence after radiotherapy].
    Rubio AP; López IJ
    Arch Esp Urol; 2012; 65(1):145-57. PubMed ID: 22318185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.